4D Molecular Therapeutics, Inc. Common Stock
Symbol: FDMT (NASDAQ)
10.94
▼ (-2.96%) -0.334
Company Description:
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
Key Stats
- Today's Open: $11.14
- Today's High: $11.705
- Today's Low: $10.723
- Today's Volume: 778.55K
- Yesterday Close: $11.27
- Yesterday High: $11.29
- Yesterday Low: $9.93
- Yesterday Volume: 932.91K
- Last Min Volume: 0
- Last Min High: $10.971
- Last Min Low: $10.936
- Last Min VWAP: $0
Company Profile
- Name: 4D Molecular Therapeutics, Inc. Common Stock
- Website: https://www.4dmoleculartherapeutics.com
- Listed Date: 2020-12-11
- Location: EMERYVILLE, CA
- Market Status: Active
- CIK Number: 0001650648
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $526.34M
- Round Lot: 100
- Outstanding Shares: 46.70M
- Asset Type: CS
RECENT FILINGS FOR FDMT
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-20 | 4 | View |
| 2025-10-20 | SCHEDULE 13G | View |
| 2025-10-17 | SCHEDULE 13G/A | View |
| 2025-10-14 | 4 | View |
| 2025-10-10 | 3 | View |
| 2025-10-02 | 8-K | View |
| 2025-09-26 | 4 | View |
| 2025-09-23 | 144 | View |
| 2025-08-11 | 10-Q | View |
| 2025-08-11 | 8-K | View |
| 2025-07-02 | 8-K | View |
| 2025-06-20 | 4 | View |
| 2025-06-20 | 4 | View |
| 2025-06-20 | 4 | View |
| 2025-06-20 | 4 | View |
| 2025-06-20 | 4 | View |
| 2025-06-20 | 4 | View |
| 2025-06-20 | 8-K | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
Latest News on FDMT